Maxicef OF 200mg/200mg Tablet is a combination antibiotic formulation containing Cefixime 200mg and Ofloxacin 200mg, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Ofloxacin, a fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. This synergistic combination enhances antibacterial efficacy against both Gram-positive and Gram-negative pathogens, including strains resistant to single-agent therapy. Maxicef OF is indicated for respiratory tract infections, urinary tract infections, otitis media, gonorrhea, and skin and soft tissue infections. It is particularly useful in cases where polymicrobial infections are suspected or when resistance to monotherapy is a concern. The tablet should be administered orally with or without food, following the prescribed dosage regimen to ensure optimal therapeutic outcomes and minimize resistance development. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and renal function should be monitored during prolonged therapy. Common adverse effects may include gastrointestinal disturbances, headache, and dizziness. Maxicef OF should be used under medical supervision to ensure safety and efficacy.